John J. Harrington, Chief Scientific Officer at ATHERSYS, INC / NEW (ATHX), sold 23,709 shares at $3.54 ($86K) on 2014-03-18, disclosed to the SEC on 2014-03-20.
Scheduled sale ($86k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.54 | 8,150 | $29K | 33.4% |
| 2 | $3.69 | 15,559 | $57K | 66.6% |
| Total | $3.64 avg | 23,709 | $86K | 100% |
| Filing → |
| ATHX | SELL | 2021-06-08 | $47K | — | Filing → |
| ATHX | SELL | 2021-06-02 | $36K | — | Filing → |
| ATHX | SELL | 2021-03-17 | $20K | — | Filing → |